From TC privately: "The site won’t let me post another

New Post Public Reply Private Reply Replies (0) Message Board
BusyBee BusyBee #269
228
From TC privately:

"The site won’t let me post another reply without upgrading to premium. Any way, if you want to share this, you can.

The ones that bought shares will have now bought them from Apex. Apex filled them with short shares and that is why they have to cover. The buyers should be ok."


Of course! Shame on me for not figuring that out myself. Ugh. That definitely imposes a penalty on APEX. Good.

And good for those who picked up cheap shares!

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Impact of Indiana Court Ruling on Industry Liability Claims

Updated Category News Views 94

Significance of the Indiana Court Ruling In a landmark decision, the Indiana Court of Appeals unanimously resolved a long-standing legal battle by dismissing a lawsuit against firearm manufacturers initiated by the City of Gary. This case spanned 26 years and sought to place accountability on gun makers for crimes committed by third parties. With this ruling, the court...

Continue Reading
Riot Platforms Shares Key Insights on Bitcoin Production

Updated Category News Views 155

Riot Platforms Shares Key Insights on Bitcoin Production Riot Platforms, Inc. (NASDAQ: RIOT), a leader in the Bitcoin mining industry, recently announced significant updates regarding their production operations for the month of March. The company proudly reported the successful production of 533 Bitcoin during this period, underscoring their commitment to maintaining...

Continue Reading
Telix Pharmaceuticals Advances Kidney Cancer Imaging with TLX250-CDx

Updated Category News Views 162

Telix Pharmaceuticals' Breakthrough in Kidney Cancer Imaging Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX) has made significant strides forward in the field of kidney cancer diagnostics with the FDA's acceptance of its Biologics License Application (BLA) for TLX250-CDx, also known as Zircaix. This important step brings the company closer to potentially...

Continue Reading
Transforming Restaurant Operations: Lightspeed and 7shifts Join Forces

Updated Category News Views 283

Lightspeed and 7shifts Partnership Overview In an exciting development for the restaurant industry, Lightspeed Commerce Inc. has expanded its partnership with 7shifts, a leader in workforce management for restaurants. This collaboration aims to enhance payroll processing and operational efficiency for establishments across North America. Together, they are set to...

Continue Reading
Tint World Achieves Impressive Ranking in Inc. 5000 List

Updated Category News Views 148

Tint World® Achieves Notable Milestone Tint World® Automotive Styling Centers™, renowned for excellence in automotive styling, proudly ranks No. 4,836 on the esteemed Inc. 5000 list of fastest-growing private companies in America. This achievement, underpinned by a remarkable three-year revenue growth of 57.55 percent, marks the tenth occasion Tint World has earned a...

Continue Reading